|
Paxlovid Efficacy Not Established for Certain Cohorts
|
|
Pharmacists often encounter patients who have tested positive but are not at an elevated risk for severe COVID-19 and now want a prescription for Paxlovid. Find out why a new study suggests that might not be a good idea, explaining that the efficacy of the nirmatrelvir-ritonavir combination has not been established in that cohort.
|
|
|
RSV Severity Comparable to COVID-19, Flu in Unvaccinated Adults
|
|
|
The lack of a clear public health directive for older adults to receive a respiratory syncytial virus (RSV) vaccine might suggest otherwise, but a new study found that before the approval of the vaccines, cases of RSV were at least as severe as COVID-19 or influenza among unvaccinated patients and were actually more severe than in those who were hospitalized after having been vaccinated against flu and COVID-19. Read more.
|
|
New Injectable Antibiotic Approved to Treat Three Difficult Infections
|
|
|
Staphylococcus aureus bloodstream infections in adults, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia in adults and pediatric patients (aged 3 months and older) can be notoriously hard to treat, especially in a hospital setting. Now, the FDA has approved a new injectable antibiotic, ceftobiprole medocaril sodium, to battle those infections. Read more.
|
|
|
Use of IV Vasoactive Drugs, Albumin in Cirrhosis
|
|
In patients with decompensated cirrhosis and/or variceal hemorrhage, vasoconstrictors decrease portal pressure by causing splanchnic vasoconstriction. To address developments in the management of cirrhosis, the American Gastroenterological Association released a clinical practice update with best practice recommendations for the use of IV vasoactive drugs and IV albumin in three areas. Read more.
|
|
